en |
Prediabetes in Colombia: Expert Consensus
López-Jaramillo, Patricio; Calderón, Carlos; Castillo, Jorge; Escobar, Iván Darío; Melgarejo, Enrique & Parra, Gustavo Adolfo
Abstract
The prevalence of Prediabetes in Colombia is high, and despite being
recognized and categorized in the main Medical Guidelines and included
in the International Classification of Diseases in Colombia, knowledge
and awareness of it is limited amongst healthcare professionals and in the
community. Our expert group recommends that educational programs
emphasize a global approach to risk which includes a recognition
of the importance of prediabetes and its evaluation along with and
other risk factors such as a family history of DM2, overweight and
obesity, dislipidemia and hypertension. Studies conducted in Colombia
demonstrate the value of the FINDRIS questionnaire as a tool to identify
subjects at risk of prediabetes and DM2, and we recommend that it should
be systematic applied throughout the country as part of government policy.
Prediabetes progresses to DM2 at an annual rate of 10%, but it has also been
shown that prediabetes is an independent risk factor for cardiovascular
outcomes. On this basis, the Committee recommends that once prediabetes
is detected and diagnosed, immediate management of the disease begins
through lifestyle changes, with follow up assessments performed at 3 and
6 months. If the patient does not respond with a weight loss of at least 5%
and if the HbA1C values are not normalized, pharmacological management
should be initiated with a metformin dose of 500 mg / day, increasing up to
1,500 - 1,700 mg / day, according to tolerance.
Keywords
Prediabetes; diabetes mellitus type 2; cardiovascular diseases; Colombia
|